CONVERGEN
LIVE

Serial Number

99040419

Owner

Convergen Biotech, Inc.

Attorney

Michael J Leonard

Filing Date

Feb 13, 2025

Add to watchlist:

No watchlists yet
View on USPTO

CONVERGEN Trademark

Serial Number: 99040419

CONVERGEN is a trademark filed by Convergen Biotech, Inc. on February 13, 2025. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently pending registration.

Owner Contact Info

Convergen Biotech, Inc.

3300 Bee Cave Road, Suite 650-227
Austin, TX 78746

Entity Type: 03

Trademark Details

Filing Date

February 13, 2025

Registration Date

Not Registered

Goods & Services

medical research services; medical research laboratory services; pharmaceutical research and development services; medical and scientific research information in the field of healthcare; scientific and technological product research services for others in the field of diabetes

Pharmaceutical and medical preparations and agents for the prevention and treatment of diabetes and metabolic diseases/disorders; chemical and biological preparations for treating diabetes; pharmaceutical preparations and substances for the treatment of endocrinological diseases and disorders

Filing History

REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
May 14, 2026 RCSC
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
May 7, 2026 RCCK
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Nov 5, 2025 GNS3
LETTER OF SUSPENSION E-MAILED
Nov 5, 2025 GNSL
SUSPENSION LETTER WRITTEN
Nov 5, 2025 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Nov 4, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 4, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Nov 4, 2025 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Aug 5, 2025 GNRN
NON-FINAL ACTION E-MAILED
Aug 5, 2025 GNRT
NON-FINAL ACTION WRITTEN
Aug 5, 2025 CNRT
ASSIGNED TO EXAMINER
Jul 22, 2025 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 9, 2025 NWOS
APPLICATION FILING RECEIPT MAILED
Feb 13, 2025 MAFR
NEW APPLICATION ENTERED
Feb 13, 2025 NWAP